Erratum: Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses (Journal of Biological Chemistry (2010) 107, 2 (598-603) DOI: 10.1073/pnas.0911748107);Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 2, 2010, Pages 598-603

  Lai, Samuel K ^a   Wang, Ying Ying ^b   Hida, Kaoru ^b   Cone, Richard ^a,c   Hanes, Justin ^a,b  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervicovaginal tract; Herpes simplex virus; Hydrophobic interactions; Microstructure; Particle tracking

Indexed keywords

MUCIN; NANOPARTICLE;

ARTICLE; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HYDROPHOBICITY; MUCOADHESION; MUCUS; POROSITY; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VAGINA FLORA;

SIMPLEXVIRUS;

EID: 76249115874     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111693108     Document Type: Erratum

References (58)

1. Cone R (2005) Mucosal Immunology, eds Mestecky J, et al. (Academic, San Diego), pp 49-72.
2. Gipson IK (2005) Human endocervical mucins. Ernst Schering Res Found Workshop 219-244.
3. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest, 109:571-577.
4. Chilvers MA, O'Callaghan C (2000) Local mucociliary defence mechanisms. Paediatr Respir Rev, 1:27-34.
5. Carlstedt I, Sheehan JK (1989) Structure and macromolecular properties of cervical mucus glycoproteins. Symp Soc Exp Biol, 43:289-316.
6. Lai SK, et al. (2007) Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA, 104:1482-1487.
7. Lai SK, Wang YY, Hanes J (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev, 61:158-171.
8. Olmsted SS, et al. (2001) Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J, 81:1930-1937.
9. Lai SK, Wang YY, Wirtz D, Hanes J (2009) Micro- and macrorheology of mucus. Adv Drug Deliv Rev, 61:86-100.
10. Saltzman WM, Radomsky ML, Whaley KJ, Cone RA (1994) Antibody diffusion in human cervical mucus. Biophys J, 66:508-515.
11. Yudin AI, Hanson FW, Katz DF (1989) Human cervical mucus and its interaction with sperm: A fine-structural view. Biol Reprod, 40:661-671.
12. Ceric F, Silva D, Vigil P (2005) Ultrastructure of the human periovulatory cervical mucus. J Electron Microsc, 54:479-484.
13. Chretien FC, Cohen J, Borg V, Psychoyos A (1975) Human cervical mucus during the menstrual cycle and pregnancy in normal and pathological conditions. J Reprod Med, 14:192-196.
14. Poon WW, McCoshen JA (1985) Variances in mucus architecture as a cause of cervical factor infertility. Fertil Steril, 44:361-365.
15. O'Mullane JE, Artursson P, Tomlinson E (1987) Biopharmaceutics of microparticulate drug carriers. Ann NY Acad Sci, 507:120-140.
16. Sanders NN, et al. (2000) Cystic fibrosis sputum: A barrier to the transport of nanospheres. Am J Respir Crit Care Med, 162:1905-1911.
17. Wang YY, et al. (2008) Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew Chem Int Ed Engl, 47:9726-9729.
18. Suh J, Dawson M, Hanes J (2005) Real-time multiple-particle tracking: Applications to drug and gene delivery. Adv Drug Deliv Rev, 57:63-78.
19. Amsden B (1998) Solute diffusion within hydrogels. Mechanisms and models. Macromolecules, 31:8382-8395.
20. Amsden B (1999) An obstruction-scaling model for diffusion in homogeneous hydrogels. Macromolecules, 32:874-879.
21. Shen H, Hu Y, SaltzmanWM(2006) DNA diffusion in mucus: Effect of size, topology of DNAs, and transfection reagents. Biophys J, 91:639-644.
22. Sheehan JK, Oates K, Carlstedt I (1986) Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. Biochem J, 239:147-153.
23. Slayter HS, Wold JK, Midtvedt T (1991) Intestinal mucin of germ-free rats. Biochemical and electron-microscopic characterization. Carbohydr Res, 222:1-9.
24. Allen A, Flemstrom G, Garner A, Kivilaakso E (1993) Gastroduodenal mucosal protection. Physiol Rev, 73:823-857.
25. Carlstedt I, Lindgren H, Sheehan JK, Ulmsten U, Wingerup L (1983) Isolation and characterization of human cervical-mucus glycoproteins. Biochem J, 211:13-22.
26. Chao CC, Butala SM, Herp A (1988) Studies on the isolation and composition of human ocular mucin. Exp Eye Res, 47:185-196.
27. Quraishi MS, Jones NS, Mason J (1998) The rheology of nasal mucus: A review. Clin Otolaryngol Allied Sci, 23:403-413.
28. Samet JM, Cheng PW (1994) The role of airway mucus in pulmonary toxicology. Environ Health Perspect, 102(Suppl 2):89-103.
29. Biehl R, et al. (2004) Diffusion of compact macromolecules through polymer meshes: Mesh dynamics and probe dynamics. Phys B, 350:76-78.
30. Sheehan JK, Carlstedt I (1984) Hydrodynamic properties of human cervical-mucus glycoproteins in 6M-guanidinium chloride. Biochem J, 217:93-101.
31. Lai SK, Wang YY, Cone R, Wirtz D, Hanes J (2009) Altering mucus rheology to "solidify" human mucus at the nanoscale. PLoS One, 4:e4294.
32. Slomiany BL, Tsukada H, Slomiany A (1986) Cotranslational attachment of fatty acids to nascent peptides in gastric mucus glycoprotein. Biochem Biophys Res Commun, 141:387-393.
33. Brunelli R, et al. (2007) Globular structure of human ovulatory cervical mucus. FASEB J, 21:3872-3876.
34. Cao X, et al. (1999) pH-dependent conformational change of gastric mucin leads to sol-gel transition. Biophys J, 76:1250-1258.
35. Hong Z, et al. (2005) Atomic force microscopy reveals aggregation of gastric mucin at low pH. Biomacromolecules, 6:3458-3466.
36. Lai SK, et al. (2009) HIV is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol.
37. Cone RA (2009) Barrier properties of mucus. Adv Drug Deliv Rev, 61:75-85.
38. Girod S, Zahm JM, Plotkowski C, Beck G, Puchelle E (1992) Role of the physiochemical properties of mucus in the protection of the respiratory epithelium. Eur Respir J, 5:477-487.
39. King M (2006) Physiology of mucus clearance. Paediatr Respir Rev, 7(Suppl 1): S212-214.
40. Rubin BK (2007) Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev, 8:4-7.
41. Shirazi T, Longman RJ, Corfield AP, Probert CS (2000) Mucins and inflammatory bowel disease. Postgrad Med J, 76:473-478.
42. Cone RA, et al. (2006) Vaginal microbicides: Detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis, 6:90.
43. Galen BT, et al. (2007) A comprehensive murine model to evaluate topical vaginal microbicides: Mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. J Infect Dis, 195:1332-1339.
44. Phillips DM, Zacharopoulos VR (1998) Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice. Contraception, 57:341-348.
45. Van Damme L, et al. (2002) Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet, 360:971-977.
46. Haines-Butterick L, et al. (2007) Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells. Proc Natl Acad Sci USA, 104:7791-7796.
47. Suk JS, et al. (2009) The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials, 30:2591-2597.
48. Matsui H, et al. (2005) Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J Immunol, 175:1090-1099.
49. Fleming DT, et al. (1997) Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med, 337:1105-1111.
50. Mbopi-Keou FX, et al. (2000) Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: Opportunities for intervention. J Infect Dis, 182:1090-1096.
51. Allsworth JE, Peipert JF (2007) Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol, 109:114-120.
52. Olmsted SS, Meyn LA, Rohan LC, Hillier SL (2003) Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis, 30:257-261.
53. Martin HL, et al. (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis, 180:1863-1868.
54. Taha TE, et al. (1998) Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS, 12:1699-1706.
55. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL (2003) Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis, 37:319-325.
56. Boskey ER, Moench TR, Hees PS, Cone RA (2003) A self-sampling method to obtain large volumes of undiluted cervicovaginal secretions. Sex Transm Dis, 30:107-109.
57. Apgar J, et al. (2000) Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles. Biophys J, 79:1095-1106.
58. Dawson M, Wirtz D, Hanes J (2003) Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J Biol Chem, 278:50393-50401.